BioXcel Therapeutics, Inc.
USD1.40
+0.00 (+0.00%)
CEO
Vimal D. Mehta
IPO Date
2018-03-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.40
Prev. Close
$1.40
Day Low
$1.38
Day High
$1.43
52W Low
$1.01
52W High
$8.08
Market Cap
$0.04B
Volume
0.24M
| -0.3 |
| 31 Dec 2023 | FY | 8.7% | -12974.9% | 316.9% | -242.9% | -1.79 | 2.65 | -0.5 |
| 31 Dec 2022 | FY | 94.7% | -44201.9% | -215.9% | -80.5% | 1.23 | 6.17 | -3.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -48.2% | -44.7% | 0.01 | 14.21 | -5.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -39.8% | -37.4% | 0.01 | 18.33 | -12.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -120.2% | -88.9% | 0.04 | 4.03 | -7.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -49.6% | -44.2% | 0.00 | 9.26 | -2.9 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 462.2% | -335.0% | -0.38 | 0.38 | -40.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 654.3% | -30285.7% | 0.00 | 0.01 | -85.7 |
| -0.4 |
| 30 Sept 2025 | Q3 | 88.8% | -31541.8% | 34.8% | -69.0% | -1.23 | 1.17 | -0.3 |
| 30 Jun 2025 | Q2 | 10.8% | -15989.2% | 17.8% | -74.4% | -1.01 | 0.76 | -0.2 |
| 31 Mar 2025 | Q1 | 91.7% | -4317.9% | 8.0% | -18.8% | -1.17 | 1.48 | -0.3 |
| 31 Dec 2024 | Q4 | -127.3% | -2966.9% | 11.7% | -28.3% | -1.11 | 1.68 | -0.4 |
| 30 Sept 2024 | Q3 | -446.7% | -6378.5% | 15.9% | -27.9% | -1.23 | 1.87 | -0.5 |
| 30 Jun 2024 | Q2 | 94.4% | -751.7% | 11.2% | -12.7% | -1.39 | 2.35 | -1.4 |
| 31 Mar 2024 | Q1 | 72.9% | -4603.3% | 37.0% | -32.5% | -1.41 | 2.57 | -0.8 |
| 31 Dec 2023 | Q4 | -89.9% | -5919.1% | 39.4% | -30.2% | -1.79 | 2.65 | -1.0 |